Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00161928
Status:
COMPLETED
Last Update Posted:
2015-05-21
First Post:
2005-09-08
Brief Title:
Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Randomized Open-Label Trial of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary aim of the study is to show that NeisVac-C does not influence the seroconversion rates induced by hepatitis B Hep B inactivated polio IPV and acellular pertussis aP vaccines in infants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None